CBT
IDXX icon

Central Bank & Trust’s Idexx Laboratories IDXX Stock Holding History

Central Bank & Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21
Closed -$10.2K – 268
2024
Q2 		$10.2K Hold
21
– – ﹤0.01% 313
2024
Q1 		$11.3K Hold
21
– – ﹤0.01% 290
2023
Q4 		$11.7K Hold
21
– – ﹤0.01% 301
2023
Q3 		$9.18K Hold
21
– – ﹤0.01% 288
2023
Q2 		$10.5K Sell
21
-8
-28% -$3.83K ﹤0.01% 276
2023
Q1 		$14.5K Buy
29
+8
+38% +$3.83K ﹤0.01% 268
2022
Q4 		$8.57K Hold
21
– – ﹤0.01% 294
2022
Q3 		$7K Hold
21
– – ﹤0.01% 288
2022
Q2 		$7K Hold
21
– – ﹤0.01% 287
2022
Q1 		$11K Buy
+21
New +$11K ﹤0.01% 283

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Central Bank & Trust's IDXX Position: Q3 2024 in Review

Central Bank & Trust sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 21 shares — an estimated $10.2K sold.

Central Bank & Trust first reported a position in IDXX in Q1 2022 and held it in 10 quarters. The position peaked at $14.5K in Q1 2023. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Central Bank & Trust reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Central Bank & Trust sold 21 Idexx Laboratories shares in Q3 2024, an estimated $10.2K.
  • Central Bank & Trust first reported a position in Idexx Laboratories in Q1 2022 and held it in 10 quarters.
  • Central Bank & Trust's Idexx Laboratories position peaked at $14.5K in Q1 2023.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Central Bank & Trust's 13F filing for Q3 2024, filed 30 Oct 2024.